| Year |
Citation |
Score |
| 2023 |
Wu T, Pelus LM, Plett PA, Sampson CH, Chua HL, Fisher A, Feng H, Liu L, Li H, Ortiz M, Chittajallu S, Luo Q, Bhatwadekar AD, Meyer TB, Zhang X, et al. Further Characterization of Multi-Organ DEARE and Protection by 16,16 Dimethyl Prostaglandin E2 in a Mouse Model of the Hematopoietic Acute Radiation Syndrome. Radiation Research. PMID 37014943 DOI: 10.1667/RADE-22-00208.1 |
0.322 |
|
| 2022 |
Fukuda S, Matsuda N, Shoji T, Onishi C, Hirade T, Taketani T, Pelus LM. The magnitude of CXCR4 signaling regulates resistance to quizartinib in FLT3/ITD cells via RUNX1. Leukemia Research. 124: 106983. PMID 36473282 DOI: 10.1016/j.leukres.2022.106983 |
0.331 |
|
| 2022 |
Patterson AM, Orschell CM, Pelus LM. Hematopoietic Stem Cell Identification Postirradiation. Methods in Molecular Biology (Clifton, N.J.). 2567: 127-140. PMID 36255699 DOI: 10.1007/978-1-0716-2679-5_9 |
0.367 |
|
| 2022 |
Hoggatt J, Pelus LM. The Factory of Blood Production: Hematopoietic Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 2567: 3-7. PMID 36255691 DOI: 10.1007/978-1-0716-2679-5_1 |
0.734 |
|
| 2022 |
Liu L, Li H, Patterson AM, Plett PA, Sampson CH, Mohammad KS, Capitano ML, Singh P, Yao C, Orschell CM, Pelus LM. Upregulation of SIRT1 Contributes to dmPGE2-dependent Radioprotection of Hematopoietic Stem Cells. Stem Cell Reviews and Reports. PMID 35318613 DOI: 10.1007/s12015-022-10368-2 |
0.378 |
|
| 2021 |
Patterson AM, Zhang S, Liu L, Li H, Singh P, Liu Y, Farag SS, Pelus LM. Meloxicam with Filgrastim may Reduce Oxidative Stress in Hematopoietic Progenitor Cells during Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Multiple Myeloma. Stem Cell Reviews and Reports. PMID 34510361 DOI: 10.1007/s12015-021-10259-y |
0.414 |
|
| 2021 |
Singh P, Pelus LM. Prostaglandin E Regulates Bipotent Monocyte-Dendritic Progenitor Cell Lineage-Commitment. Stem Cell Reviews and Reports. PMID 34159458 DOI: 10.1007/s12015-021-10202-1 |
0.408 |
|
| 2021 |
Patterson AM, Plett PA, Sampson CH, Simpson E, Liu Y, Pelus LM, Orschell CM. Prostaglandin E Enhances Aged Hematopoietic Stem Cell Function. Stem Cell Reviews and Reports. PMID 33974233 DOI: 10.1007/s12015-021-10177-z |
0.365 |
|
| 2020 |
Patterson AM, Wu T, Chua HL, Sampson CH, Fisher A, Singh P, Guise TA, Feng H, Muldoon J, Wright L, Plett PA, Pelus LM, Orschell CM. Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome. Radiation Research. PMID 33302300 DOI: 10.1667/RADE-20-00181.1 |
0.392 |
|
| 2020 |
Patterson AM, Liu L, Sampson CH, Plett PA, Li H, Singh P, Mohammad KS, Hoggatt J, Capitano ML, Orschell CM, Pelus LM. A Single Radioprotective Dose of Prostaglandin E Blocks Irradiation-Induced Apoptotic Signaling and Early Cycling of Hematopoietic Stem Cells. Stem Cell Reports. PMID 32735825 DOI: 10.1016/J.Stemcr.2020.07.004 |
0.741 |
|
| 2020 |
Singh P, Kacena MA, Orschell CM, Pelus LM. Aging-Related Reduced Expression of CXCR4 on Bone Marrow Mesenchymal Stromal Cells Contributes to Hematopoietic Stem and Progenitor Cell Defects. Stem Cell Reviews and Reports. PMID 32418119 DOI: 10.1007/S12015-020-09974-9 |
0.506 |
|
| 2020 |
Singh P, Mohammad KS, Pelus LM. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation. Stem Cells (Dayton, Ohio). PMID 32159901 DOI: 10.1002/Stem.3174 |
0.605 |
|
| 2019 |
Maupin KA, Himes ER, Plett AP, Chua HL, Singh P, Ghosh J, Mohamad SF, Abeysekera I, Fisher A, Sampson C, Hong JM, Childress P, Alvarez M, Srour EF, Bruzzaniti A, ... Pelus LM, et al. Aging negatively impacts the ability of megakaryocytes to stimulate osteoblast proliferation and bone mass. Bone. PMID 31299382 DOI: 10.1016/J.Bone.2019.07.010 |
0.419 |
|
| 2018 |
Pelus LM, Broxmeyer HE. Peripheral blood stem cell mobilization; a look ahead. Current Stem Cell Reports. 4: 273-281. PMID 31131207 DOI: 10.1007/S40778-018-0141-9 |
0.542 |
|
| 2018 |
Patterson AM, Pelus LM. Spotlight on Glycolysis: A New Target for Cord Blood Expansion. Cell Stem Cell. 22: 792-793. PMID 29859169 DOI: 10.1016/J.Stem.2018.04.023 |
0.45 |
|
| 2018 |
Singh P, Li H, Pelus LM. Engraftment and Reconstitution of Hematopoiesis Is Dependent on Endothelial Cell Expressed Prostaglandin EP4 Receptor Signaling Mediated Regeneration of Vascular Niche Blood. 132: 1293-1293. DOI: 10.1182/Blood-2018-99-119723 |
0.544 |
|
| 2017 |
Patterson AM, Pelus LM. G-CSF in stem cell mobilization: new insights, new questions. Annals of Blood. 2. PMID 30465039 DOI: 10.21037/Aob.2017.06.02 |
0.555 |
|
| 2017 |
Hoggatt J, Singh P, Tate TA, Chou BK, Datari SR, Fukuda S, Liu L, Kharchenko PV, Schajnovitz A, Baryawno N, Mercier FE, Boyer J, Gardner J, Morrow DM, Scadden DT, ... Pelus LM, et al. Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. Cell. PMID 29224778 DOI: 10.1016/J.Cell.2017.11.003 |
0.778 |
|
| 2017 |
Singh P, Hoggatt J, Kamocka MM, Mohammad KS, Saunders MR, Li H, Speth J, Carlesso N, Guise TA, Pelus LM. Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells. The Journal of Clinical Investigation. PMID 29130940 DOI: 10.1172/Jci94687 |
0.812 |
|
| 2017 |
Singh P, Fukuda S, Liu L, Chitteti BR, Pelus LM. Survivin is Required for Mouse and Human Bone Marrow Mesenchymal Stromal Cell Function. Stem Cells (Dayton, Ohio). PMID 29067757 DOI: 10.1002/Stem.2727 |
0.489 |
|
| 2017 |
Singh P, Pelus LM. IFN-1 Bid crosstalk: foe or friend to stem cells. Stem Cell Investigation. 4: 18. PMID 28275648 DOI: 10.21037/Sci.2017.02.06 |
0.492 |
|
| 2017 |
Pelus LM. Stem Cell Reviews and Reports: Cell Trafficking, Stem Cell Mobilization and Homing, and Hematopoiesis Section. Stem Cell Reviews. PMID 28210846 DOI: 10.1007/S12015-017-9726-4 |
0.495 |
|
| 2017 |
Singh P, Kacena MA, Orschell CM, Pelus LM. Attenuation of CXCR4/SDF-1 Axis in Bone Marrow Mesenchymal Stromal Cells Impairs Hematopoietic Niche Activity and Promotes Stem Cell Aging Blood. 130: 92-92. DOI: 10.1182/Blood.V130.Suppl_1.92.92 |
0.52 |
|
| 2016 |
Abe M, Pelus LM, Singh P, Hirade T, Onishi C, Purevsuren J, Taketani T, Yamaguchi S, Fukuda S. Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells. Plos One. 11: e0158290. PMID 27387666 DOI: 10.1371/Journal.Pone.0158290 |
0.46 |
|
| 2016 |
Singh P, Pelus LM. CXCR4-SDF-1 Signaling in Nestin+ Mesenchymal Stem Cell Is Required for HSC Maintenance during Homeostasis and Regeneration after Irradiation Blood. 128: 3883-3883. DOI: 10.1182/Blood.V128.22.3883.3883 |
0.584 |
|
| 2016 |
Singh P, Pelus LM. Neuropeptide Y Is Critical for Bone Marrow Stromal Cells and Hematopoietic Recovery Following Injury Blood. 128: 173-173. DOI: 10.1182/Blood.V128.22.173.173 |
0.568 |
|
| 2016 |
Patterson AM, Singh P, Li H, Chua HL, Fisher A, Sampson C, Plett A, Orschell CM, Pelus LM. Prostaglandin E2 Promotes Early Bone Marrow Reconstitution for Survival after Lethal Irradiation Blood. 128: 1481-1481. DOI: 10.1182/Blood.V128.22.1481.1481 |
0.444 |
|
| 2015 |
Hoggatt J, Hoggatt AF, Tate TA, Fortman J, Pelus LM. Bleeding the Laboratory Mouse: Not All Methods are Equal. Experimental Hematology. PMID 26644183 DOI: 10.1016/J.Exphem.2015.10.008 |
0.695 |
|
| 2015 |
Mantel CR, O'Leary HA, Chitteti BR, Huang X, Cooper S, Hangoc G, Brustovetsky N, Srour EF, Lee MR, Messina-Graham S, Haas DM, Falah N, Kapur R, Pelus LM, Bardeesy N, et al. Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock. Cell. 161: 1553-65. PMID 26073944 DOI: 10.1016/J.Cell.2015.04.054 |
0.516 |
|
| 2015 |
Balogh A, Shimizu Y, Lee SC, Norman DD, Gangwar R, Bavaria M, Moon C, Shukla P, Rao R, Ray R, Naren AP, Banerje S, Miller DD, Balazs L, Pelus L, et al. The autotaxin-LPA2 GPCR axis is modulated by γ-irradiation and facilitates DNA damage repair. Cellular Signalling. 27: 1751-62. PMID 26027517 DOI: 10.1016/J.Cellsig.2015.05.015 |
0.391 |
|
| 2015 |
Hoggatt J, Tate TA, Pelus LM. Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia. International Journal of Nanomedicine. 10: 2647-52. PMID 25878498 DOI: 10.2147/Ijn.S55796 |
0.692 |
|
| 2015 |
Fukuda S, Hoggatt J, Singh P, Abe M, Speth JM, Hu P, Conway EM, Nucifora G, Yamaguchi S, Pelus LM. Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1. Leukemia. 29: 433-40. PMID 24903482 DOI: 10.1038/Leu.2014.183 |
0.825 |
|
| 2015 |
Singh P, Orschell CM, Pelus LM. Prostaglandin E2 Signaling through EP4 Receptor Promotes Hematopoietic Stem Cell Niche Regeneration and Enhances Hematopoietic Recovery Blood. 126: 784-784. DOI: 10.1182/Blood.V126.23.784.784 |
0.552 |
|
| 2014 |
Hoggatt J, Tate TA, Pelus LM. Hematopoietic stem and progenitor cell mobilization in mice. Methods in Molecular Biology (Clifton, N.J.). 1185: 43-64. PMID 25062621 DOI: 10.1007/978-1-4939-1133-2_4 |
0.772 |
|
| 2014 |
Chitteti BR, Kobayashi M, Cheng Y, Zhang H, Poteat BA, Broxmeyer HE, Pelus LM, Hanenberg H, Zollman A, Kamocka MM, Carlesso N, Cardoso AA, Kacena MA, Srour EF. CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche. Blood. 124: 519-29. PMID 24740813 DOI: 10.1182/Blood-2014-03-565721 |
0.399 |
|
| 2014 |
Broxmeyer HE, Pelus LM. Inhibition of DPP4/CD26 and dmPGE₂ treatment enhances engraftment of mouse bone marrow hematopoietic stem cells. Blood Cells, Molecules & Diseases. 53: 34-8. PMID 24602918 DOI: 10.1016/J.Bcmd.2014.02.002 |
0.598 |
|
| 2014 |
Pelus LM, Singh P. Delta-1 provides pleasant stem cell environs. Blood. 123: 605-6. PMID 24482496 DOI: 10.1182/Blood-2013-12-539841 |
0.397 |
|
| 2014 |
Speth JM, Hoggatt J, Singh P, Pelus LM. Pharmacologic increase in HIF1α enhances hematopoietic stem and progenitor homing and engraftment. Blood. 123: 203-7. PMID 24167196 DOI: 10.1182/Blood-2013-07-516336 |
0.847 |
|
| 2014 |
Hoggatt J, Pelus LM. New G-CSF agonists for neutropenia therapy. Expert Opinion On Investigational Drugs. 23: 21-35. PMID 24073859 DOI: 10.1517/13543784.2013.838558 |
0.739 |
|
| 2014 |
Gang EJ, Hsieh YT, Pham J, Zhao Y, Nguyen C, Huantes S, Park E, Naing K, Klemm L, Swaminathan S, Conway EM, Pelus LM, Crispino J, Mullighan CG, McMillan M, et al. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Oncogene. 33: 2169-78. PMID 23728349 DOI: 10.1038/Onc.2013.169 |
0.392 |
|
| 2014 |
Singh P, Fukuda S, Saunders MR, Pelus LM. Survivin Is a Master Regulator of Mesenchymal Stem Cell Functions and Potential Therapeutic Target for Mesenchymal Stem Cell Expansion Blood. 124: 774-774. DOI: 10.1182/Blood.V124.21.774.774 |
0.55 |
|
| 2014 |
Mantel C, O'Leary HA, Chitteti BR, Huang X, Cooper S, Hangoc G, Brustovetsky N, Srour EF, Lee MR, Messina-Graham S, Falah N, Kapur R, Pelus LM, Ivan M, Kim K, et al. Mitigation of a Newly Discovered Phenomenon, Extra Physiologic Oxygen Shock/Stress (EPHOSS), Mediated By the Mitochondria Permeability Transition Pore, Greatly Improves Stem Cell Collection and Transplantation Blood. 124: 2905-2905. DOI: 10.1182/Blood.V124.21.2905.2905 |
0.541 |
|
| 2013 |
Hoggatt J, Pelus LM. How beneficial is the use of NSAIDs in stem-cell transplantation? Expert Opinion On Pharmacotherapy. 14: 2453-6. PMID 24138174 DOI: 10.1517/14656566.2013.849243 |
0.773 |
|
| 2013 |
Hoggatt J, Speth JM, Pelus LM. Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilization. Stem Cells (Dayton, Ohio). 31: 2599-606. PMID 24123398 DOI: 10.1002/Stem.1574 |
0.831 |
|
| 2013 |
Hoggatt J, Mohammad KS, Singh P, Pelus LM. Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness. Blood. 122: 2997-3000. PMID 24047650 DOI: 10.1182/Blood-2013-07-515288 |
0.743 |
|
| 2013 |
Cutler C, Multani P, Robbins D, Kim HT, Le T, Hoggatt J, Pelus LM, Desponts C, Chen YB, Rezner B, Armand P, Koreth J, Glotzbecker B, Ho VT, Alyea E, et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood. 122: 3074-81. PMID 23996087 DOI: 10.1182/Blood-2013-05-503177 |
0.748 |
|
| 2013 |
Zhao W, Breese E, Bowers A, Hoggatt J, Pelus LM, Broxmeyer HE, Goebl M, Harrington MA. SIMPL enhancement of tumor necrosis factor-α dependent p65-MED1 complex formation is required for mammalian hematopoietic stem and progenitor cell function. Plos One. 8: e61123. PMID 23630580 DOI: 10.1371/Journal.Pone.0061123 |
0.685 |
|
| 2013 |
Hoggatt J, Mohammad KS, Singh P, Hoggatt AF, Chitteti BR, Speth JM, Hu P, Poteat BA, Stilger KN, Ferraro F, Silberstein L, Wong FK, Farag SS, Czader M, Milne GL, ... ... Pelus LM, et al. Differential stem- and progenitor-cell trafficking by prostaglandin E2. Nature. 495: 365-9. PMID 23485965 DOI: 10.1038/Nature11929 |
0.847 |
|
| 2013 |
Hoggatt J, Singh P, Stilger KN, Plett PA, Sampson CH, Chua HL, Orschell CM, Pelus LM. Recovery from hematopoietic injury by modulating prostaglandin E(2) signaling post-irradiation. Blood Cells, Molecules & Diseases. 50: 147-53. PMID 23206586 DOI: 10.1016/J.Bcmd.2012.11.006 |
0.746 |
|
| 2013 |
Speth JM, Capitano ML, Hoggatt J, Pelus LM. Hif1α and Rac1 Are Necessary For Enhanced HSPC Migration and Homing In Response To Prostaglandin E2 Treatment Blood. 122: 889-889. DOI: 10.1182/Blood.V122.21.889.889 |
0.783 |
|
| 2013 |
Singh P, Mohammad K, Hoggatt J, Speth JM, Pelus LM. Bone Marrow Sinusoidal Integrity Regulates Hematopoietic Stem and Progenitor Cell Trafficking Blood. 122: 3687-3687. DOI: 10.1182/Blood.V122.21.3687.3687 |
0.837 |
|
| 2012 |
Broxmeyer HE, Hoggatt J, O'Leary HA, Mantel C, Chitteti BR, Cooper S, Messina-Graham S, Hangoc G, Farag S, Rohrabaugh SL, Ou X, Speth J, Pelus LM, Srour EF, Campbell TB. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nature Medicine. 18: 1786-96. PMID 23160239 DOI: 10.1038/Nm.2991 |
0.825 |
|
| 2012 |
Hoggatt J, Pelus LM. Hematopoietic stem cell mobilization with agents other than G-CSF. Methods in Molecular Biology (Clifton, N.J.). 904: 49-67. PMID 22890921 DOI: 10.1007/978-1-61779-943-3_4 |
0.764 |
|
| 2012 |
Singh P, Hu P, Hoggatt J, Moh A, Pelus LM. Expansion of bone marrow neutrophils following G-CSF administration in mice results in osteolineage cell apoptosis and mobilization of hematopoietic stem and progenitor cells. Leukemia. 26: 2375-83. PMID 22543963 DOI: 10.1038/Leu.2012.117 |
0.784 |
|
| 2012 |
Singh P, Hoggatt J, Hu P, Speth JM, Fukuda S, Breyer RM, Pelus LM. Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood. 119: 1671-82. PMID 22110249 DOI: 10.1182/Blood-2011-03-342428 |
0.806 |
|
| 2012 |
Chitteti BR, Kobayashi M, Cheng Y, Hu P, Poteat B, Broxmeyer HE, Pelus LM, Kacena MA, Srour EF. CD166 (ALCAM): A Functional Marker of Primitive Murine and Human Hematopoietic Stem Cells and Cellular Elements of Their Niche Blood. 120: 640-640. DOI: 10.1182/Blood.V120.21.640.640 |
0.443 |
|
| 2012 |
Singh P, Hoggatt J, Hu P, Pelus LM. Sinusoidal Endothelial CD26 Cleavage of Neuropeptide Y Regulates Transendothelial Migration and Mobilization of Hematopoietic Stem and Progenitor Cells in Response to G-CSF. Blood. 120: 2347-2347. DOI: 10.1182/Blood.V120.21.2347.2347 |
0.728 |
|
| 2012 |
Fukuda S, Abe M, Hirade T, Onishi C, Pelus LM, Yamaguchi S. The Internal-Tandem-Duplication of Flt3 Mutation Generates Growth Inhibitory Signals in Mouse Hematopoietic Progenitor Cells by Down-Regulating Pbx1 Expression Via P21cdkn1a. Blood. 120: 2340-2340. DOI: 10.1182/Blood.V120.21.2340.2340 |
0.455 |
|
| 2011 |
Pelus LM, Farag SS. Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma. Stem Cells and Cloning : Advances and Applications. 4: 11-22. PMID 24198526 DOI: 10.2147/SCCAA.S6713 |
0.347 |
|
| 2011 |
Pelus LM, Hoggatt J. Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function. Prostaglandins & Other Lipid Mediators. 96: 3-9. PMID 21722751 DOI: 10.1016/J.Prostaglandins.2011.06.004 |
0.773 |
|
| 2011 |
Hoggatt J, Pelus LM. Many mechanisms mediating mobilization: an alliterative review. Current Opinion in Hematology. 18: 231-8. PMID 21537168 DOI: 10.1097/Moh.0B013E3283477962 |
0.77 |
|
| 2011 |
Pelus LM, Hoggatt J, Singh P. Pulse exposure of haematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery. Cell Proliferation. 22-9. PMID 21481039 DOI: 10.1111/J.1365-2184.2010.00726.X |
0.712 |
|
| 2011 |
Hoggatt J, Pelus LM. Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment. Stem Cell Research & Therapy. 2: 13. PMID 21418553 DOI: 10.1186/Scrt54 |
0.782 |
|
| 2011 |
Fukuda S, Abe M, Onishi C, Taketani T, Purevsuren J, Yamaguchi S, Conway EM, Pelus LM. Survivin selectively modulates genes deregulated in human leukemia stem cells. Journal of Oncology. 2011: 946936. PMID 21253548 DOI: 10.1155/2011/946936 |
0.496 |
|
| 2011 |
Speth JM, Hoggatt J, Pelus LM. Enhanced Homing of HSPCs After Treatment with Prostaglandin E2 (PGE2) May Be An Effect of Transcriptional Regulation of CXC Chemokine Receptor 4 (CXCR4) Through Hypoxia Inducible Factor 1α (HIF1α) Blood. 118: 918-918. DOI: 10.1182/Blood.V118.21.918.918 |
0.844 |
|
| 2011 |
Hoggatt J, Mohammad KS, Chitteti BR, Singh P, Speth JM, Hu P, Poteat B, Srour E, Guise T, Pelus LM. Bone Marrow Niche Attenuation by Non-Steroidal Anti-Inflammatory Drugs Mobilizes Hematopoietic Stem and Progenitor Cells by Differing Mechanisms Blood. 118: 724-724. DOI: 10.1182/Blood.V118.21.724.724 |
0.841 |
|
| 2010 |
Hoggatt J, Pelus LM. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia. 24: 1993-2002. PMID 20882043 DOI: 10.1038/Leu.2010.216 |
0.795 |
|
| 2010 |
Hoggatt AF, Hoggatt J, Honerlaw M, Pelus LM. A spoonful of sugar helps the medicine go down: a novel technique to improve oral gavage in mice. Journal of the American Association For Laboratory Animal Science : Jaalas. 49: 329-34. PMID 20587165 |
0.607 |
|
| 2010 |
Hoggatt J, Singh P, Hoggatt A, Speth JM, Pelus LM. Nonsteroidal anti-inflammatory drugs (NSAIDs) or EP4 receptor antagonism enhances hematopoietic stem and progenitor cell (HSPC) mobilization and facilitates faster hematopoietic recovery after myeloablation. Journal of Clinical Oncology. 28: 6604-6604. DOI: 10.1200/Jco.2010.28.15_Suppl.6604 |
0.772 |
|
| 2010 |
Singh P, Speth J, Hu P, Pelus LM. CXCR4-SDF-1 Signaling Mediated up-Regulation of Survivin Expression In Mesenchymal Progenitor Cells Is Critical for Their Proliferation and Maintenance of Osteoblastic Niche Blood. 116: 941-941. DOI: 10.1182/Blood.V116.21.941.941 |
0.79 |
|
| 2010 |
Fukuda S, Singh P, Hoggatt J, Speth J, Abe M, Conway EM, Crispino J, Nucifora G, Yamaguchi S, Pelus LM. Survivin Modulates Gene Expression That Connects through An Extensive Functional Signaling Network and Regulates Proliferation of Hematopoietic Stem Cells through Evi-1 Blood. 116: 87-87. DOI: 10.1182/Blood.V116.21.87.87 |
0.833 |
|
| 2010 |
Hoggatt J, Chitteti BR, Krishna V, Farag S, Czader M, Yoder MC, Srour E, Pelus LM. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Alter the Hematopoietic Niche and Treatment In Healthy Volunteers Results In Mobilization of CD34+ Cells, Hematopoietic Colony Forming Cells, and Endothelial Colony Forming Cells Blood. 116: 556-556. DOI: 10.1182/Blood.V116.21.556.556 |
0.782 |
|
| 2010 |
Abe M, Pelus LM, Singh P, Yamaguchi S, Taketani T, Fukuda S. p21WAF1/CDKN1 Function In Hematopoietic Progenitor Cell Proliferation Is Inversely Regulated by Wild-Type Flt3 and Internal Tandem Duplication Mutation of Flt3 Blood. 116: 4175-4175. DOI: 10.1182/Blood.V116.21.4175.4175 |
0.388 |
|
| 2010 |
Park E, Jiang E, Hsieh Y, Klemm L, Duy C, Conway EM, Pelus LM, Crispino J, Loh ML, Kang E, Koo H, Yang A, Heisterkamp N, Kahn M, Muschen M, et al. Targeting Survivin In Recalcitrant Acute Lymphoblastic Leukemia Blood. 116: 3263-3263. DOI: 10.1182/Blood.V116.21.3263.3263 |
0.432 |
|
| 2010 |
Hoggatt J, Plett A, Sampson C, Chua HL, Orschell CM, Pelus LM. Recovery of Hematopoiesis and Increased Survival Following Radiological Injury through Modulation of Prostaglandin E2 (PGE2) Signaling. Blood. 116: 2638-2638. DOI: 10.1182/Blood.V116.21.2638.2638 |
0.717 |
|
| 2010 |
Singh, P, Hoggatt J, Speth J, Pelus LM. Prostaglandin E2 Modulates Monocytes and Dendritic Cells Specific Progenitor Cell (MDP) Fate by Regulating M-CSF Receptor and Flt3 Receptor Expression. Blood. 116: 2636-2636. DOI: 10.1182/Blood.V116.21.2636.2636 |
0.82 |
|
| 2009 |
Fukuda S, Singh P, Moh A, Abe M, Conway EM, Boswell HS, Yamaguchi S, Fu XY, Pelus LM. Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3. Blood. 114: 394-403. PMID 19411632 DOI: 10.1182/Blood-2008-11-188714 |
0.514 |
|
| 2009 |
Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 113: 5444-55. PMID 19324903 DOI: 10.1182/Blood-2009-01-201335 |
0.781 |
|
| 2009 |
Hoggatt J, Singh P, Hoggatt A, Speth JM, Pelus LM. Inhibition of Prostaglandin E2 (PGE2) Signaling by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or EP4 Receptor Antagonism Expands Hematopoietic Stem and Progenitor Cells (HSPC) and Enhances Their Mobilization to Peripheral Blood in Mice and Baboons. Blood. 114: 84-84. DOI: 10.1182/Blood.V114.22.84.84 |
0.824 |
|
| 2009 |
Abe M, Pelus LM, Taketani T, Yamaguchi S, Fukuda S. Internal Tandem Duplication Mutations of Flt3 (ITD-Flt3) up-Regulate p21 WAF1/CDKN1 Protein That Negatively Regulates Aberrant Proliferation of Hematopoietic Cells Induced by ITD-Flt3. Blood. 114: 5037-5037. DOI: 10.1182/Blood.V114.22.5037.5037 |
0.408 |
|
| 2009 |
Broxmeyer HE, Hoggatt J, Cooper S, Hangoc G, Pelus LM, Campbell TB. CD26/Dipeptidylpeptidase IV Regulates Potency of Selected Hematopoietic Growth Factors through Truncation, and Recovery In Vivo After Cytotoxic Stress. Blood. 114: 3602-3602. DOI: 10.1182/Blood.V114.22.3602.3602 |
0.733 |
|
| 2009 |
Fukuda S, Mori S, Abe M, Yamaguchi S, Pelus LM. ITD-Flt3 Enhances Migration of Hematopoietic Cells through Aberrant CXCR4 Signaling Pathways Overlapping but Functionally Distinct From SDF1/CXCR4 Signaling Axis in Normal Hematopoietic Cells. Blood. 114: 2383-2383. DOI: 10.1182/Blood.V114.22.2383.2383 |
0.488 |
|
| 2009 |
Singh P, Hoggatt J, Speth JM, Pelus LM. Cyclooxygenase-2 Derived Prostaglandin E2 Is Required for Dendritic Cell Differentiation From Hematopoietic Progenitor Cells. Blood. 114: 1499-1499. DOI: 10.1182/Blood.V114.22.1499.1499 |
0.814 |
|
| 2008 |
Pelus LM. Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand. Current Opinion in Hematology. 15: 285-92. PMID 18536564 DOI: 10.1097/Moh.0B013E328302F43A |
0.587 |
|
| 2008 |
Fukuda S, Pelus LM. Transmigration of human CD34+ cells. Methods in Molecular Biology (Clifton, N.J.). 430: 55-75. PMID 18370291 DOI: 10.1007/978-1-59745-182-6_4 |
0.537 |
|
| 2008 |
Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 Enhances Survival, Proliferation, Homing and Engraftment of Mouse Hematopoietic Stem Cells Blood. 112: 74-74. DOI: 10.1182/Blood.V112.11.74.74 |
0.798 |
|
| 2008 |
Pelus LM, Singh P. The Combination of AMD3100 Plus GROβ Rapidly Mobilizes Hematopoietic Stem Cells with Enhanced Homing, Adhesion and Survival Properties Blood. 112: 71-71. DOI: 10.1182/Blood.V112.11.71.71 |
0.488 |
|
| 2008 |
Singh P, Fukuda S, Sampath J, Pelus LM. G-CSF Mediated Decrease in Bone-Marrow SDF-1 Level Is Neutrophil Dependent but CD26 Independent Blood. 112: 3469-3469. DOI: 10.1182/Blood.V112.11.3469.3469 |
0.481 |
|
| 2008 |
Fukuda S, Abe M, Yamaguchi S, Pelus LM. Overlapping but Distinct Role of p21WAF1/CDKN1 and Survivin in Hematopoietic Progenitor Cell Proliferation. Blood. 112: 1334-1334. DOI: 10.1182/Blood.V112.11.1334.1334 |
0.465 |
|
| 2008 |
Sampath J, Smith L, Pelus LM. Identification and Characterization of Sur3γ and Sur3γV, Two Novel Splice Variants of Survivin in HSPC Blood. 112: 1323-1323. DOI: 10.1182/Blood.V112.11.1323.1323 |
0.453 |
|
| 2007 |
Sampath J, Pelus LM. Alternative splice variants of survivin as potential targets in cancer. Current Drug Discovery Technologies. 4: 174-91. PMID 17986000 DOI: 10.2174/157016307782109652 |
0.308 |
|
| 2007 |
Pelus LM, Fukuda S. Chemokine-mobilized adult stem cells; defining a better hematopoietic graft. Leukemia. 22: 466-73. PMID 17972941 DOI: 10.1038/Sj.Leu.2405021 |
0.587 |
|
| 2007 |
Fukuda S, Bian H, King AG, Pelus LM. The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood. 110: 860-9. PMID 17416737 DOI: 10.1182/Blood-2006-06-031401 |
0.584 |
|
| 2007 |
Mantel C, Guo Y, Lee MR, Kim MK, Han MK, Shibayama H, Fukuda S, Yoder MC, Pelus LM, Kim KS, Broxmeyer HE. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability. Blood. 109: 4518-27. PMID 17289813 DOI: 10.1182/Blood-2006-10-054247 |
0.441 |
|
| 2007 |
Fukuda S, Sigh P, Conway EM, Yamaguchi S, Pelus LM. Survivin Regulates Aberrant Proliferation of Hematopoietic Progenitor Cells with Self Renewal Capability and Development of Acute Leukemia Induced by Internal-Tandem-Duplication of Flt3. Blood. 110: 599-599. DOI: 10.1182/Blood.V110.11.599.599 |
0.508 |
|
| 2007 |
Guzman JR, Fukuda S, Pelus L. Survivin Inhibition of p34Cdc2 Via Protection of Wee1 Correlates with Survival. Blood. 110: 3352-3352. DOI: 10.1182/Blood.V110.11.3352.3352 |
0.377 |
|
| 2007 |
Singh P, Pelus LM. CD26 Expression on Neutrophils Is Critical for G-CSF Mediated Mobilization of Hematopoietic Stem and Progenitor Cells. Blood. 110: 1267-1267. DOI: 10.1182/Blood.V110.11.1267.1267 |
0.453 |
|
| 2006 |
Broxmeyer HE, Pelus LM, Kim CH, Hangoc G, Cooper S, Hromas R. Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C. Experimental Hematology. 34: 1069-77. PMID 16863913 DOI: 10.1016/J.Exphem.2006.04.007 |
0.492 |
|
| 2006 |
Fukuda S, Pelus LM. Internal tandem duplication of Flt3 modulates chemotaxis and survival of hematopoietic cells by SDF1alpha but negatively regulates marrow homing in vivo. Experimental Hematology. 34: 1041-51. PMID 16863910 DOI: 10.1016/J.Exphem.2006.04.001 |
0.498 |
|
| 2006 |
Pelus LM, Fukuda S. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Experimental Hematology. 34: 1010-20. PMID 16863907 DOI: 10.1016/J.Exphem.2006.04.004 |
0.579 |
|
| 2006 |
Fukuda S, Conway EM, Pelus LM. Survivin Regulates Proliferation of Normal Hematopoietic Stem and Progenitor Cells In Vivo. Blood. 108: 859-859. DOI: 10.1182/Blood.V108.11.859.859 |
0.58 |
|
| 2006 |
Pelus LM, Fukuda S, Bridger G. The CXCR4 Antagonist AMD3100 and the CXCR2 Agonist GROβ Synergistically Mobilize Hematopoetic Stem Cells (HSC) with Short and Long Term Repopulating Activity. Blood. 108: 339-339. DOI: 10.1182/Blood.V108.11.339.339 |
0.484 |
|
| 2006 |
Pelus LM, Clapp DW, Bridger G. Suprasynergistic Peripheral Blood Stem Cell Mobilization in Normal and Fanconi Anemia Knockout Mice by the Combination of G-CSF Plus the CXCR4 Antagonist AMD3100 and the CXCR2 Agonist GRO β Blood. 108: 3185-3185. DOI: 10.1182/Blood.V108.11.3185.3185 |
0.415 |
|
| 2005 |
Guo Y, Hangoc G, Bian H, Pelus LM, Broxmeyer HE. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells (Dayton, Ohio). 23: 1324-32. PMID 16210409 DOI: 10.1634/Stemcells.2005-0085 |
0.553 |
|
| 2005 |
Wang Z, Sampath J, Fukuda S, Pelus LM. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis. Cancer Research. 65: 8224-32. PMID 16166298 DOI: 10.1158/0008-5472.Can-05-0303 |
0.359 |
|
| 2005 |
Pelus LM, Bian H, Fukuda S, Wong D, Merzouk A, Salari H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Experimental Hematology. 33: 295-307. PMID 15730853 DOI: 10.1016/J.Exphem.2004.11.008 |
0.508 |
|
| 2005 |
Fukuda S, Broxmeyer HE, Pelus LM. Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis. Blood. 105: 3117-26. PMID 15618475 DOI: 10.1182/Blood-2004-04-1440 |
0.468 |
|
| 2005 |
Okabe S, Fukuda S, Kim YJ, Niki M, Pelus LM, Ohyashiki K, Pandolfi PP, Broxmeyer HE. Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1. Blood. 105: 474-80. PMID 15345598 DOI: 10.1182/Blood-2004-03-0843 |
0.34 |
|
| 2005 |
Fukuda S, Bian H, Conway EM, Pelus LM. The Survivin/p21WAF1/Cip1 Axis and the CXC Chemokine SDF1α Regulate Growth Factor Independent Survival of Primary Hematopoietic Progenitor Cells Induced by Internal Tandem Duplication Mutations of Flt3. Blood. 106: 1611-1611. DOI: 10.1182/Blood.V106.11.1611.1611 |
0.466 |
|
| 2005 |
Pelus LM, Bian H, King AG, Fukuda S. PBSC Mobilization by the Chemokine GROβ Alone and in Combination with G-CSF in Mice Demonstrates the Same Inter-Strain Variability in Mobilization Response as G-CSF and Is Dependent upon Differences in Neutrophil Pro-MMP-9 Content and Release. Blood. 106: 1272-1272. DOI: 10.1182/Blood.V106.11.1272.1272 |
0.411 |
|
| 2004 |
Fukuda S, Pelus LM. Activated H-Ras regulates hematopoietic cell survival by modulating Survivin. Biochemical and Biophysical Research Communications. 323: 636-44. PMID 15369798 DOI: 10.1016/J.Bbrc.2004.08.149 |
0.309 |
|
| 2004 |
Wang Z, Fukuda S, Pelus LM. Survivin regulates the p53 tumor suppressor gene family. Oncogene. 23: 8146-53. PMID 15361831 DOI: 10.1038/Sj.Onc.1207992 |
0.331 |
|
| 2004 |
Fukuda S, Mantel CR, Pelus LM. Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. Blood. 103: 120-7. PMID 12969960 DOI: 10.1182/Blood-2003-05-1756 |
0.389 |
|
| 2004 |
Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. Blood. 103: 110-9. PMID 12958067 DOI: 10.1182/Blood-2003-04-1115 |
0.418 |
|
| 2004 |
Merzouk A, Wong D, Salari H, Bian H, Fukuda S, Pelus L. Rational Design of Chemokine SDF-1 Analogs with Agonist Activity for the CXCR4 Receptor and the Capacity to Rapidly Mobilize PMN and Hematopoietic Progenitor Cells in Mice Letters in Drug Design & Discovery. 1: 126-134. DOI: 10.2174/1570180043485608 |
0.443 |
|
| 2004 |
Fukuda S, Broxmeyer HE, Pelus LM. Flt3 Ligand Negatively Regulates In Vitro Migration, Intracellular Signaling Activated by SDF-1α/CXCR4 and In Vivo Homing of Hematopoietic Progenitor Cells. Blood. 104: 2674-2674. DOI: 10.1182/Blood.V104.11.2674.2674 |
0.514 |
|
| 2004 |
Wang Z, Fukuda S, Pelus LM. Disruption of the Inhibitor-Of-Apoptosis Protein, Survivin, Sensitizes Bcr-abl Positive Cells to STI571 (Gleevec®)-Induced Apoptosis. Blood. 104: 2578-2578. DOI: 10.1182/Blood.V104.11.2578.2578 |
0.391 |
|
| 2004 |
Guo Y, Hangoc G, Bian H, Pelus LM, Broxmeyer HE. SDF-1/CXCL12 Enhances Survival of Murine Embryonic Stem Cells and Their Production of Myeloid Progenitors, but Not Hemangioblasts. Blood. 104: 1693-1693. DOI: 10.1182/Blood.V104.11.1693.1693 |
0.528 |
|
| 2004 |
Mantel C, Guo Y, Shibayama H, Fukuda S, Yoder MC, Pelus LM, Broxmeyer HE. Checkpoint Adaptation and Apoptosis Are Uncoupled in Mouse ES Cell Lines. Blood. 104: 1259-1259. DOI: 10.1182/Blood.V104.11.1259.1259 |
0.399 |
|
| 2004 |
Fukuda S, Pelus LM. Internal Tandem Duplication of Flt3 (ITD-Flt3) Bypasses Growth Factor Mediated Survivin Expression, while Disruption of Survivin Accelerates Cell Death in Hematopoietic Cells Expressing ITD-Flt3. Blood. 104: 1256-1256. DOI: 10.1182/Blood.V104.11.1256.1256 |
0.474 |
|
| 2002 |
Fukuda S, Pelus LM. Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle (Georgetown, Tex.). 1: 322-6. PMID 12461294 |
0.393 |
|
| 2002 |
Pelus LM, Horowitz D, Cooper SC, King AG. Peripheral blood stem cell mobilization. A role for CXC chemokines. Critical Reviews in Oncology/Hematology. 43: 257-75. PMID 12270782 DOI: 10.1016/S1040-8428(01)00202-5 |
0.575 |
|
| 2002 |
Fukuda S, Foster RG, Porter SB, Pelus LM. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood. 100: 2463-71. PMID 12239157 DOI: 10.1182/Blood.V100.7.2463 |
0.477 |
|
| 2002 |
Horowitz D, Callahan JF, Pelus LM, Fukuda S, King AG. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products. International Immunopharmacology. 2: 721-30. PMID 12013510 DOI: 10.1016/S1567-5769(02)00007-3 |
0.469 |
|
| 2002 |
Fukuda S, Wu DW, Stark K, Pelus LM. Cloning and characterization of a proliferation-associated cytokine-inducible protein, CIP29. Biochemical and Biophysical Research Communications. 292: 593-600. PMID 11922608 DOI: 10.1006/Bbrc.2002.6680 |
0.464 |
|
| 2001 |
Fukuda S, Pelus LM. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood. 98: 2091-100. PMID 11567995 DOI: 10.1182/Blood.V98.7.2091 |
0.48 |
|
| 2001 |
King AG, Horowitz D, Dillon SB, Levin R, Farese AM, MacVittie TJ, Pelus LM. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood. 97: 1534-42. PMID 11238087 DOI: 10.1182/blood.V97.6.1534 |
0.429 |
|
| 2000 |
Erickson-Miller CL, Pelus LM, Lord KA. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Stem Cells (Dayton, Ohio). 18: 366-73. PMID 11007921 DOI: 10.1634/Stemcells.18-5-366 |
0.46 |
|
| 2000 |
Wu DW, Stark KC, Dunnington D, Dillon SB, Yi T, Jones C, Pelus LM. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells. Blood Cells, Molecules & Diseases. 26: 15-24. PMID 10772872 DOI: 10.1006/Bcmd.2000.0273 |
0.35 |
|
| 2000 |
King AG, Johanson K, Frey CL, DeMarsh PL, White JR, McDevitt P, McNulty D, Balcarek J, Jonak ZL, Bhatnagar PK, Pelus LM. Identification of unique truncated KC/GRO beta chemokines with potent hematopoietic and anti-infective activities. Journal of Immunology (Baltimore, Md. : 1950). 164: 3774-82. PMID 10725737 DOI: 10.4049/Jimmunol.164.7.3774 |
0.434 |
|
| 1999 |
Broxmeyer HE, Kim CH, Cooper SH, Hangoc G, Hromas R, Pelus LM. Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors Annals of the New York Academy of Sciences. 872: 142-163. PMID 10372118 DOI: 10.1111/J.1749-6632.1999.Tb08460.X |
0.452 |
|
| 1999 |
Kim CH, Pelus LM, Appelbaum E, Johanson K, Anzai N, Broxmeyer HE. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cellular Immunology. 193: 226-35. PMID 10222066 DOI: 10.1006/Cimm.1999.1483 |
0.408 |
|
| 1998 |
Tian SS, Lamb P, King AG, Miller SG, Kessler L, Luengo JI, Averill L, Johnson RK, Gleason JG, Pelus LM, Dillon SB, Rosen J. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (New York, N.Y.). 281: 257-9. PMID 9657720 DOI: 10.1126/Science.281.5374.257 |
0.425 |
|
| 1998 |
Kim CH, Pelus LM, White JR, Broxmeyer HE. Differential Chemotactic Behavior of Developing T Cells in Response to Thymic Chemokines Blood. 91: 4434-4443. DOI: 10.1182/Blood.V91.12.4434 |
0.338 |
|
| 1996 |
Bhatnagar PK, Agner EK, Alberts D, Arbo BE, Callahan JF, Cuthbertson AS, Engelsen SJ, Fjerdingstad H, Hartmann M, Heerding D, Hiebl J, Huffman WF, Hysben M, King AG, Kremminger P, ... ... Pelus LM, et al. Structure-activity relationships of novel hematoregulatory peptides. Journal of Medicinal Chemistry. 39: 3814-9. PMID 8809169 DOI: 10.1021/Jm960099D |
0.32 |
|
| 1991 |
Talmadge JE, Pelus LM, Black PL, Abe F. Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice Biomedicine and Pharmacotherapy. 45: 61-69. PMID 1912371 DOI: 10.1016/0753-3322(91)90124-C |
0.328 |
|
| 1990 |
Talmadge JE, Black PL, Pelus LM, Abe F. Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 44: 85-91. PMID 2224059 DOI: 10.1016/0753-3322(90)90109-M |
0.386 |
|
| 1989 |
Nocka KH, Ottman OG, Pelus LM. The role of marrow accessory cell populations in the augmentation of human erythroid progenitor cell (BFU-E) proliferation by prostaglandin E. Leukemia Research. 13: 527-34. PMID 2788237 DOI: 10.1016/0145-2126(89)90119-7 |
0.391 |
|
| 1988 |
Pelus LM, Vadhan-Raj S. Modulation of responsiveness of chronic myelogenous leukemia granulocyte-macrophage colony-forming cells to growth regulation following in vivo treatment with recombinant gamma-interferon. American Journal of Hematology. 28: 21-6. PMID 3130750 DOI: 10.1002/ajh.2830280105 |
0.31 |
|
| 1988 |
Pelus L, Gentile P. In vivo modulation of myelopoiesis by prostaglandin E2. III. Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation Blood. 71: 1633-1640. DOI: 10.1182/blood.v71.6.1633.bloodjournal7161633 |
0.388 |
|
| 1988 |
Pelus L, Gentile P. In vivo modulation of myelopoiesis by prostaglandin E2. III. Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation Blood. 71: 1633-1640. DOI: 10.1182/blood.v71.6.1633.1633 |
0.388 |
|
| 1983 |
Gentile P, Byer D, Pelus L. In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2 Blood. 62: 1100-1107. DOI: 10.1182/blood.v62.5.1100.bloodjournal6251100 |
0.357 |
|
| 1983 |
Gentile P, Byer D, Pelus L. In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2 Blood. 62: 1100-1107. DOI: 10.1182/Blood.V62.5.1100.1100 |
0.462 |
|
| 1979 |
Pelus LM, Broxmeyer HE, Kurland JI, Moore MA. Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. The Journal of Experimental Medicine. 150: 277-92. PMID 313430 DOI: 10.1084/Jem.150.2.277 |
0.352 |
|
| 1978 |
Kurland J, Broxmeyer H, Pelus L, Bockman R, Moore M. Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation Blood. 52: 388-407. DOI: 10.1182/blood.V52.2.388.bloodjournal522388 |
0.322 |
|
| 1978 |
Kurland J, Broxmeyer H, Pelus L, Bockman R, Moore M. Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation Blood. 52: 388-407. DOI: 10.1182/blood.v52.2.388.388 |
0.322 |
|
| Show low-probability matches. |